1.15
price down icon2.54%   -0.03
after-market Handel nachbörslich: 1.11 -0.04 -3.48%
loading
Schlusskurs vom Vortag:
$1.18
Offen:
$1.16
24-Stunden-Volumen:
111.27K
Relative Volume:
0.28
Marktkapitalisierung:
$75.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-86.08M
KGV:
-0.4475
EPS:
-2.57
Netto-Cashflow:
$-72.06M
1W Leistung:
-11.20%
1M Leistung:
+0.00%
6M Leistung:
-22.30%
1J Leistung:
+29.21%
1-Tages-Spanne:
Value
$1.11
$1.19
1-Wochen-Bereich:
Value
$1.11
$1.36
52-Wochen-Spanne:
Value
$0.7327
$2.098

Io Biotech Inc Stock (IOBT) Company Profile

Name
Firmenname
Io Biotech Inc
Name
Telefon
(457) 070-2980
Name
Adresse
OLE MAALOES VEH 3, COPENHAGEN
Name
Mitarbeiter
68
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
IOBT's Discussions on Twitter

Io Biotech Inc Aktie (IOBT) Neueste Nachrichten

pulisher
Nov 03, 2024

Here's Why We're A Bit Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Situation - Yahoo Finance

Nov 03, 2024
pulisher
Oct 30, 2024

Legend Biotech Chooses Philadelphia for New R&D Center - BioBuzz

Oct 30, 2024
pulisher
Oct 29, 2024

Short Interest in IO Biotech, Inc. (NASDAQ:IOBT) Declines By 12.7% - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Melanoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Oct 28, 2024
pulisher
Oct 27, 2024

IO Biotech, Inc. (NASDAQ:IOBT) Shares Sold by Novo Holdings A S - MarketBeat

Oct 27, 2024
pulisher
Oct 23, 2024

TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail

Oct 23, 2024
pulisher
Oct 17, 2024

Melanoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, - openPR

Oct 17, 2024
pulisher
Oct 17, 2024

Melanoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, MOA, ROA, Companies by DelveInsight - Barchart

Oct 17, 2024
pulisher
Oct 13, 2024

38,076 Shares in Montauk Renewables, Inc. (NASDAQ:MNTK) Bought by Squarepoint Ops LLC - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Bank of America Boosts Voya Financial (NYSE:VOYA) Price Target to $88.00 - Defense World

Oct 13, 2024
pulisher
Oct 11, 2024

IO Biotech, Inc. (NASDAQ:IOBT) Short Interest Update - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Norstella introduces a fully integrated data asset for biopharma - European Pharmaceutical Manufacturer

Oct 11, 2024
pulisher
Oct 11, 2024

Immuno-Oncology Clinical Trials Market Valuation to Reach $18.1 Billion By 2032 - 대구포스트

Oct 11, 2024
pulisher
Oct 05, 2024

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting - ForexTV.com

Oct 05, 2024
pulisher
Oct 04, 2024

VerImmune Secures $4.5 Million to Drive Biotech Innovation - BioBuzz

Oct 04, 2024
pulisher
Oct 04, 2024

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting - The Manila Times

Oct 04, 2024
pulisher
Oct 04, 2024

ARHT Media Inc. Announces Filing for Bankruptcy - The Manila Times

Oct 04, 2024
pulisher
Oct 04, 2024

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's 39th Annual Meeting - Marketscreener.com

Oct 04, 2024
pulisher
Oct 03, 2024

United States shares lower at close of trade; Dow Jones Industrial Average down 1.51% - MSN

Oct 03, 2024
pulisher
Oct 03, 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.51% - MSN

Oct 03, 2024
pulisher
Oct 01, 2024

5 Best Microbiome Companies (November 2024) - Securities.io

Oct 01, 2024
pulisher
Sep 30, 2024

ProShare Advisors LLC Sells 113 Shares of Reinsurance Group of America, Incorporated (NYSE:RGA) - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Novo Holdings A S Sells 658,809 Shares of IO Biotech, Inc. (NASDAQ:IOBT) - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

American Century Companies Inc. Purchases 75,475 Shares of Lifetime Brands, Inc. (NASDAQ:LCUT) - Defense World

Sep 30, 2024
pulisher
Sep 27, 2024

PCI Pharma Services invests over $365 million in EU and US facilities - European Pharmaceutical Manufacturer

Sep 27, 2024
pulisher
Sep 26, 2024

Sei Investments Co. Buys 24,363 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Cancer Vaccines Market Detailed In Recent Development to Grow - openPR

Sep 26, 2024
pulisher
Sep 20, 2024

U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.51% - MSN

Sep 20, 2024
pulisher
Sep 18, 2024

Investors in cash trouble should check out IO Biotech Inc (IOBT) - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 18, 2024
pulisher
Sep 18, 2024

IO Biotech (NASDAQ:IOBT) Rating Reiterated by HC Wainwright - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

IO Biotech (NASDAQ:IOBT) PT Raised to $6.00 - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

IO Biotech Inc [IOBT] moved up 3.22: Why It’s Important - The DBT News

Sep 17, 2024
pulisher
Sep 17, 2024

Stock Market Movers Today • Top Gainers & Losers - Benzinga

Sep 17, 2024
pulisher
Sep 17, 2024

Piper Sandler maintains Overweight rating on IO Biotech shares By Investing.com - Investing.com Canada

Sep 17, 2024
pulisher
Sep 16, 2024

Analyzing IO Biotech Inc (IOBT) After Recent Trading Activity - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

IOBT (IO Biotech Inc) has impressive results - US Post News

Sep 16, 2024
pulisher
Sep 16, 2024

Market Momentum: IO Biotech Inc (IOBT) Registers a -2.20 Decrease, Closing at 0.75 - The Dwinnex

Sep 16, 2024
pulisher
Sep 16, 2024

Non Small Cell Lung Cancer Pipeline Insights, Treatment Drugs, Emerging Therapies and Companies 2024 - Barchart

Sep 16, 2024
pulisher
Sep 16, 2024

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 16, 2024
pulisher
Sep 16, 2024

Examining the Potential Price Growth of McDonald’s Corp (MCD) - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Piper Sandler maintains Overweight rating on IO Biotech shares - Investing.com

Sep 16, 2024
pulisher
Sep 14, 2024

IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer - StockTitan

Sep 14, 2024
pulisher
Sep 14, 2024

IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-Line Treatment of Advanced Head and Neck Cancer - Marketscreener.com

Sep 14, 2024
pulisher
Sep 12, 2024

IOBT’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Sep 12, 2024
pulisher
Sep 10, 2024

IO Biotech Inc’s results are impressive - US Post News

Sep 10, 2024
pulisher
Sep 09, 2024

IO Biotech Inc [IOBT] Insider Activity: An Update for Investors - Knox Daily

Sep 09, 2024
pulisher
Sep 09, 2024

Ratios in Focus: Analyzing IO Biotech Inc (IOBT)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 09, 2024
pulisher
Sep 09, 2024

Morgan Stanley maintains Overweight rating on IO Biotech shares By Investing.com - Investing.com Canada

Sep 09, 2024
pulisher
Sep 06, 2024

IO Biotech stock hits 52-week low at $0.8 amid market challenges - Investing.com Canada

Sep 06, 2024
pulisher
Sep 06, 2024

It is Poised to be a Bull Market for IO Biotech Inc (IOBT) - SETE News

Sep 06, 2024

Finanzdaten der Io Biotech Inc-Aktie (IOBT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):